Regulatory CD4+CD25+ T cells in the peripheral blood of lung transplant recipients: correlation with transplant outcome. 2004

Federica Meloni, and Patrizio Vitulo, and Alessia Marone Bianco, and Enrica Paschetto, and Monica Morosini, and Alessandro Cascina, and Iolanda Mazzucchelli, and Laura Ciardelli, and Tiberio Oggionni, and Anna Maria Fietta, and Ernesto Pozzi, and Mario Viganò
Department of General Surgery and Organ Transplantation, University of Pavia and IRCCS Policlinico San Matteo, Pavia, Italy. federica_meloni@libero.it

BACKGROUND The subset of CD4+CD25+ regulatory T cells, recently identified in humans, may play a central role in the regulation of immune tolerance to graft survival. METHODS This study assesses the frequency and functional profile of CD4+CD25+CD69- cells in the peripheral blood of lung transplant recipients (>3 years from transplantation), 10 of whom were in a stable clinical condition and 11 of whom demonstrated chronic rejection (bronchiolitis obliterans syndrome). We also studied a group of seven healthy subjects. RESULTS The frequency of CD4+ T cells expressing CD25 (CD4+CD25+) and the highest levels (CD25) were lower in patients with bronchiolitis obliterans syndrome compared with healthy subjects and subjects in a stable clinical condition (P < or = 0.01). Purified CD4+CD25+ cells exhibited a regulatory functional profile in vitro: they were hyporesponsive, suppressed the proliferation of CD4+CD25- cells, and produced interleukin-10. CONCLUSIONS These results provide in vivo evidence that peripheral CD4+CD25+ T cells may represent an important regulatory subset in lung transplantation.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001989 Bronchiolitis Obliterans Inflammation of the BRONCHIOLES leading to an obstructive lung disease. Bronchioles are characterized by fibrous granulation tissue with bronchial exudates in the lumens. Clinical features include a nonproductive cough and DYSPNEA. Bronchiolitis, Exudative,Bronchiolitis, Proliferative,Constrictive Bronchiolitis,Exudative Bronchiolitis,Proliferative Bronchiolitis,Bronchiolitides, Constrictive,Bronchiolitides, Exudative,Bronchiolitides, Proliferative,Bronchiolitis, Constrictive,Constrictive Bronchiolitides,Exudative Bronchiolitides,Proliferative Bronchiolitides
D005260 Female Females
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D015375 Receptors, Interleukin-2 Receptors present on activated T-LYMPHOCYTES and B-LYMPHOCYTES that are specific for INTERLEUKIN-2 and play an important role in LYMPHOCYTE ACTIVATION. They are heterotrimeric proteins consisting of the INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT, the INTERLEUKIN-2 RECEPTOR BETA SUBUNIT, and the INTERLEUKIN RECEPTOR COMMON GAMMA-CHAIN. IL-2 Receptors,Interleukin-2 Receptor,Interleukin-2 Receptors,Receptors, IL-2,Receptors, T-Cell Growth Factor,T-Cell Growth Factor Receptors,IL-2 Receptor,IL2 Receptor,IL2 Receptors,Interleukin 2 Receptor,Receptor, TCGF,T-Cell Growth Factor Receptor,TCGF Receptor,TCGF Receptors,IL 2 Receptor,IL 2 Receptors,Interleukin 2 Receptors,Receptor, IL-2,Receptor, IL2,Receptor, Interleukin 2,Receptor, Interleukin-2,Receptors, IL 2,Receptors, IL2,Receptors, Interleukin 2,Receptors, T Cell Growth Factor,Receptors, TCGF,T Cell Growth Factor Receptor,T Cell Growth Factor Receptors
D015496 CD4-Positive T-Lymphocytes A critical subpopulation of T-lymphocytes involved in the induction of most immunological functions. The HIV virus has selective tropism for the T4 cell which expresses the CD4 phenotypic marker, a receptor for HIV. In fact, the key element in the profound immunosuppression seen in HIV infection is the depletion of this subset of T-lymphocytes. T4 Cells,T4 Lymphocytes,CD4-Positive Lymphocytes,CD4 Positive T Lymphocytes,CD4-Positive Lymphocyte,CD4-Positive T-Lymphocyte,Lymphocyte, CD4-Positive,Lymphocytes, CD4-Positive,T-Lymphocyte, CD4-Positive,T-Lymphocytes, CD4-Positive,T4 Cell,T4 Lymphocyte

Related Publications

Federica Meloni, and Patrizio Vitulo, and Alessia Marone Bianco, and Enrica Paschetto, and Monica Morosini, and Alessandro Cascina, and Iolanda Mazzucchelli, and Laura Ciardelli, and Tiberio Oggionni, and Anna Maria Fietta, and Ernesto Pozzi, and Mario Viganò
May 2007, American journal of physiology. Heart and circulatory physiology,
Federica Meloni, and Patrizio Vitulo, and Alessia Marone Bianco, and Enrica Paschetto, and Monica Morosini, and Alessandro Cascina, and Iolanda Mazzucchelli, and Laura Ciardelli, and Tiberio Oggionni, and Anna Maria Fietta, and Ernesto Pozzi, and Mario Viganò
July 2003, Immunology,
Federica Meloni, and Patrizio Vitulo, and Alessia Marone Bianco, and Enrica Paschetto, and Monica Morosini, and Alessandro Cascina, and Iolanda Mazzucchelli, and Laura Ciardelli, and Tiberio Oggionni, and Anna Maria Fietta, and Ernesto Pozzi, and Mario Viganò
August 2013, Alcoholism, clinical and experimental research,
Federica Meloni, and Patrizio Vitulo, and Alessia Marone Bianco, and Enrica Paschetto, and Monica Morosini, and Alessandro Cascina, and Iolanda Mazzucchelli, and Laura Ciardelli, and Tiberio Oggionni, and Anna Maria Fietta, and Ernesto Pozzi, and Mario Viganò
June 2003, Journal of the American Society of Nephrology : JASN,
Federica Meloni, and Patrizio Vitulo, and Alessia Marone Bianco, and Enrica Paschetto, and Monica Morosini, and Alessandro Cascina, and Iolanda Mazzucchelli, and Laura Ciardelli, and Tiberio Oggionni, and Anna Maria Fietta, and Ernesto Pozzi, and Mario Viganò
January 2003, Transplant immunology,
Federica Meloni, and Patrizio Vitulo, and Alessia Marone Bianco, and Enrica Paschetto, and Monica Morosini, and Alessandro Cascina, and Iolanda Mazzucchelli, and Laura Ciardelli, and Tiberio Oggionni, and Anna Maria Fietta, and Ernesto Pozzi, and Mario Viganò
March 2017, Parasitology research,
Federica Meloni, and Patrizio Vitulo, and Alessia Marone Bianco, and Enrica Paschetto, and Monica Morosini, and Alessandro Cascina, and Iolanda Mazzucchelli, and Laura Ciardelli, and Tiberio Oggionni, and Anna Maria Fietta, and Ernesto Pozzi, and Mario Viganò
March 2010, Medical oncology (Northwood, London, England),
Federica Meloni, and Patrizio Vitulo, and Alessia Marone Bianco, and Enrica Paschetto, and Monica Morosini, and Alessandro Cascina, and Iolanda Mazzucchelli, and Laura Ciardelli, and Tiberio Oggionni, and Anna Maria Fietta, and Ernesto Pozzi, and Mario Viganò
October 2014, Immunologic research,
Federica Meloni, and Patrizio Vitulo, and Alessia Marone Bianco, and Enrica Paschetto, and Monica Morosini, and Alessandro Cascina, and Iolanda Mazzucchelli, and Laura Ciardelli, and Tiberio Oggionni, and Anna Maria Fietta, and Ernesto Pozzi, and Mario Viganò
September 2020, Cancer immunology, immunotherapy : CII,
Federica Meloni, and Patrizio Vitulo, and Alessia Marone Bianco, and Enrica Paschetto, and Monica Morosini, and Alessandro Cascina, and Iolanda Mazzucchelli, and Laura Ciardelli, and Tiberio Oggionni, and Anna Maria Fietta, and Ernesto Pozzi, and Mario Viganò
January 2013, Transplantation proceedings,
Copied contents to your clipboard!